Manufacturing and Royalty Revenues
Revenue earned during the period from the sale of goods manufactured and royalty revenues received related to the sale, leasing or otherwise lending to a third party the entity's rights or title to under certain license arrangements.
Manufacturing and royalty revenues
COLLABORATIVE ARRANGEMENTS
Schedule of investments
Investment [Table Text Block]
Document and Entity Information
Increase (Decrease) in Inventory, Prepaid Expenses and Other Assets
Inventory, prepaid expenses and other assets
Increase (Decrease) In Inventory, prepaid expenses and other assets.
Represents the minimum number of commercial drug products in portfolio.
Minimum Number of Commercial Drug Products in Portfolio
Minimum number of commercial drug products in Company's diversified portfolio
Threshold for Disclosure Percentage
Threshold percentage for disclosure of revenue and receivables
The minimum percentage of revenues or receivables from a single customer that is used as a threshold for disclosure of a concentration of risk.
Defined Contribution Plan, Employee Contribution Limit as Percentage of Compensation
Employee contribution limit as a percentage of their eligible compensation
The limit of annual employee contributions to the plan, as a percentage of compensation.
Receipt of Company Stock for Purchase of Stock Options or to Satisfy Minimum Tax Withholding Obligations Related to Stock Based Awards, Value
Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards
This element represents Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards.
Receipt of Company Stock for the Purchase of Stock Options or to Satisfy Minimum Tax Withholding Obligations Related to Stock Based Awards, Shares
Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards (in shares)
This element represents Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards.
Shares acquired by means of net share settlements, related to the vesting of employee stock options to satisfy withholding tax obligations
Principal payments on long-term debt attributable to original issue discount
Represents principal payments of long-term debt attributable to original issue discount during the reporting period.
Payment of Instrument Principal Attributable to Original Issue Discount
Amendment Description
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale, located at third party warehouse and shipping service provider.
Inventory Finished Goods Net of Reserves Located at Third Party Warehouse and Shipping Service Provider
Finished goods inventory located at third-party warehouse and shipping service provider
Amendment Flag
Strategic equity investments
Represents information pertaining to strategic equity investments in corporations and other legal entities represented by shares of common or preferred stock (which is neither mandatorily redeemable no redeemable at the option of the holder), convertible securities, stock rights, or stock warrants.
Strategic investments
Strategic Equity Investments [Member]
Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Number of Investments Valued as Level 3
Represents the number of investments valued as level 3 of the fair value hierarchy.
Number of investments valued as level 3
Prepayment penalty in connection with debt refinancing
Prepayment of Penalty on Debt Refinancing
The cash outflow from a prepayment of penalty in connection with debt refinancing.
Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Number of Investments Transfers from Level 2 to Level 1
Number of investments transferred from level 2 to level 1
Represents the number of investments transferred into level 1 from level 2 of the fair value hierarchy.
Number of investments transferred from level 3 to level 2
Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Number of Investments Transfers from Level 3 to Level 2
Represents the number of investments transferred from level 3 to level 2 of the fair value hierarchy.
Represents the First Lien Term Loan which is due on September 16, 2017 and is secured by a first priority lien on substantially all of the assets and properties of the company and the guarantors.
First Lien Term Loan, due September 16, 2017
First Lien Term Loan, due September 16, 2017
First Lien Term Loan [Member]
First Lien Term Loan
All Countries [Domain]
Second Lien Term Loan [Member]
Second Lien Term Loan
Represents the Second Lien Term Loan which is due on September 16, 2018 and is secured by a second priority lien on substantially all of the assets and properties of the company and the guarantors.
Second Lien Term Loan, due September 16, 2018
Disclosure of the carrying value of finite-lived and indefinite-lived intangible assets, in total and by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in operations of a company.
Schedule of Finite-Lived and Indefinite-Lived Intangible Asset by Major Class [Table]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Intangible assets
Business Acquisition Cost of Acquired Entity [Table Text Block]
Schedule of purchase price of the EDT business
Disclosure of the total purchase price for the acquisition.
Schedule of Current and Noncurrent Deferred Tax Assets Liabilities [Table Text Block]
Schedule of current and non-current deferred tax assets (liabilities)
Tabular disclosure of current and noncurrent portion of deferred tax assets and liabilities.
Proceeds from the sales and maturities of marketable securities, plus the resulting realized gains and losses
Tabular disclosure of the proceeds from sales and maturities of marketable securities, plus the resulting realized gains and losses.
Proceeds and Realized Gain (Loss) on Marketable Securities [Table Text Block]
Long-term investments
Represents information pertaining to long-term investments.
Long-term Investments [Member]
Marketable Securities at Amortized Cost
Amortized Cost
Represents the cost of debt and equity securities, which are categorized as held-to-maturity, trading securities and available-for-sale, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
Gross Unrealized Losses, Less than One Year
Represents the excess of amortized cost basis over the fair value of securities that have been in a loss position for less than twelve months for those securities that are categorized as held-to-maturity, trading securities and available-for-sale.
Marketable Securities Continuous Unrealized Loss Position Less than 12 Months Aggregate Losses
Marketable Securities Continuous Unrealized Loss Position 12 Months or Longer Aggregate Losses
Gross Unrealized Losses, Greater than One Year
Represents the excess of amortized cost basis over the fair value of securities that have been in a loss position for twelve months or longer for those securities that are categorized as held-to-maturity, trading securities and available-for-sale.
Current Fiscal Year End Date
Award Type [Axis]
Realized gains
Represents the profit realized on the sale of debt or equity securities categorized as held-to-maturity, trading securities and available-for-sale.
Marketable Securities Realized Gain
Realized losses
Represents the loss realized on the sale of debt or equity securities categorized as held-to-maturity, trading securities and available-for-sale.
Marketable Securities Realized Loss
Maximum amount per employee, by the terms of the plan, that the employee may contribute to a defined contribution plan.
Per employee contribution limit
Defined Contribution Plan, Annual Contribution by Per Employee Amount
Civitas Therapeutics Inc [Member]
Civitas
Represents information pertaining to Civitas Therapeutics, Inc.
Shares of Series A preferred stock issued
Represents the total number of preferred shares issued by the equity method investee.
Equity Method Investee Preferred Stock Shares Issued
Equity Method Investee Proceeds from Preferred Stock Shares Issued
Proceeds from issuance of shares of Series A preferred stock
Represents the proceeds from issuance of preferred shares issued by the equity method investee.
Percentage of Series A preferred stock received by the entity
Represents the percentage of preferred shares, issued by the equity method investee, received by the entity.
Equity Method Investment Percentage of Preferred Stock Shares Received
Maximum employee contribution limit as a percentage of their total taxable earnings
The limit of annual employee contributions to the plan, as a percentage of their total taxable earnings.
Defined Contribution Plan, Maximum Employee Contribution Limit as Percentage of Total Taxable Earnings
Equity Method Investment Amortization Period of Deferred Gain
Period of amortization of deferred gain
Represents the period over which the gain on equity method investment will be amortized.
Furniture, fixtures and equipment
Furniture Fixture and Equipment [Member]
Represents furniture, fixture and equipment of the entity.
Stock Option and Incentive Plan 2008 [Member]
2008 Plan
Represents the 2008 Stock Option and Incentive Plan which provides for issuance of non-qualified and incentive stock options, restricted stock, restricted stock units, cash-based awards and performance shares to employees, officers and directors of, consultants to the company.
Document Period End Date
Revenues, Net [Member]
Aggregate revenues, net, during the period in the normal course of business.
Revenues, net
Name of the defined contribution plan.
Defined Contribution Benefit Plans [Domain]
Defined contribution 401 (k) plan.
401 (K) Plan
Plan 401 (K) [Member]
Defined Contribution Plan
Represents the defined contribution plan for employees outside the reporting entity's home country.
Foreign Defined Contribution Plans [Member]
2011 Plan
Represents the 2011 Stock Option and Incentive Plan which provides for issuance of non-qualified and incentive stock options, restricted stock, restricted stock units, cash-based awards and performance shares to employees, officers and directors of, consultants to the company.
Stock Option and Incentive Plan 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans under which No Further Awards will be Made
Number of share-based compensation plans under which no further awards will be made
Represents the number of equity-based compensation plans under which no further awards will be made.
Number of share-based compensation plans under which awards are currently made
Represents the number of equity-based compensation plans under which awards are currently made.
Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans under which Awards are Currently Made
Notional value
Derivative, Notional Amount
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Options Count Against Number of Shares Available for Grant Ratio
Represents the ratio of awards other than stock options counted against the total number of shares available for issuance.
Ratio of awards other than stock options counted against the total number of shares available for issuance
Share-based Compensation Arrangement by Share-based Payment Award Options Weighted Average Exercise Price [Abstract]
Weighted Average Exercise Price
Entity [Domain]
Time Vested Restricted Stock Units [Member]
Time-vested RSUs
Represents the time-vested restricted stock units awarded by the company to its employees as a form of incentive compensation.
Represents performance based restricted stock units as awarded by a company to their employees as a form of incentive compensation.
Performance-based Restricted Stock Units [Member]
Performance-based RSUs
Plan 2006 [Member]
2006 Plan
Represents information pertaining to 2006 plan.
Arrangements and Non-arrangement Transactions [Domain]
Plan 2002 [Member]
2002 Plan
Represents information pertaining to 2002 plan.
Marketable Securities [Domain]
Provides the general categories of investments that may be classified as available-for-sale, held-to-maturity and trading, for which information is required or is determined to be disclosed.
Schedule of Acquired Intangible Assets [Table Text Block]
Summary of intangible assets acquired
Tabular disclosure of the major classes of acquired intangible assets. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.
Elan Drug Technologies [Member]
EDT
Represents information pertaining to Elan Drug Technologies.
Cash Flow Reclassification [Member]
Reclassifications to statement of cash flows
Represents the activity related to reclassifications to previously reported amounts on the Statement of Cash Flows.
Operations and Comprehensive Income (Loss) Reclassification [Member]
Reclassifications to statements of operations and comprehensive income (loss)
Represents the activity related to the reclassifications to previously reported amounts on the statements of operations and comprehensive income (loss).
Business Acquisition, Pro Forma Earnings Per Share Basic and Diluted
Basic and diluted (loss) per ordinary share
The pro forma basic and diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of the period.
Intangible Assets Acquired as Part of Business Combination [Table]
A table containing detailed characteristics of finite-lived and indefinite-lived intangible assets acquired during a business combination. Intangible assets are assets that have no physical form. Acquired finite-lived and indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.
Intangible Assets Acquired as Part of Business Combination [Line Items]
Intangible assets acquired
Schedule of Defined Contribution Benefit Plans Disclosures [Table]
Disclosures about defined contribution plans.
Defined Contribution Benefit Plans [Line Items]
Employee benefit plans
Defined Contribution Benefit Plans, Disclosure Benefit Plans [Axis]
Disclosures about defined contribution plan.
Vesting Rights Percentage
Vesting rights per year (as a percent)
Description of award terms as to how many shares or portion of an award are no longer contingent on satisfaction of either a service condition, market condition or a performance condition, thereby giving the employee the legal right to convert the award to shares, shown as a percentage.
Debt Instrument, Periodic Payment as Percentage of Principal Amount
Term Loan quarterly amortization price as percentage of original principal amount
Represents the amount of the required periodic payments applied to principal as percentage of original principal amount.
Incremental capacity
Represents the amount of incremental capacity available so long as the entity meets certain conditions.
Debt Instrument Incremental Capacity Subject to Satisfaction of Certain Conditions
Operating Lease Term
Term of operating leases
Represents the term of the operating lease.
Represents the provision for extension of operating lease term.
Operating Lease Provision for Extension of Term
Provisions for extension of lease term
Total future minimum lease payments
The total of future contractually required payments on leases, net of related future sublease operating rental income receivable.
Operating Leases Future Minimum Payments Due Net of Sublease
Purchase commitments
Purchase Commitments [Abstract]
Deferred Tax Assets and Liabilities Classification [Abstract]
Schedule of current and non-current deferred tax assets (liabilities)
Tabular disclosure of current and noncurrent portion of deferred tax assets and liabilities.
Additional tax benefits from stock option exercises that have not been recognized
Deferred Tax Assets, Tax Deferred Expense Compensation and Benefits Exercise of Stock Options
Tax benefit from the exercise of stock options
The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from exercise of stock options, which can only be deducted for tax purposes when actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken.
Income Taxes [Table]
Disclosures pertaining to income taxes.
Income Taxes [Line Items]
Income taxes
Distribution of income (loss) before provision for income taxes
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from exercise of stock options, which can only be deducted for tax purposes when actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken. This element includes the additional tax benefits from the exercise of stock options related to the adoption of ASC 718, that have not been recognized in the financial statements.
Deferred Tax Assets, Tax Deferred Expense Compensation and Benefits Exercise of Stock Options Including Additional Tax Benefits
Total tax benefit from the exercise of stock options including unrecognized benefits
The component of income tax expense for the period representing amounts paid or payable as determined by applying the provisions of enacted state and local tax law to the amount of taxable transfer of intellectual property.
Current State and Local Tax Expense from Transfer of Intellectual Property
Provision on taxable transfer of the BYDEREON intellectual property
Income tax expense associated with the increase in the value of certain securities
The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to increase in fair value of securities.
Deferred Income Tax Benefit Increase in Fair Value of Securities
Tax benefit in connection with the Business Combination
The component of total income tax expense for the period comprised of an increase (decrease) during the period in the entity's domestic deferred tax assets and liabilities attributable to business combination as determined by applying the provisions of the US federally enacted tax law.
Deferred Federal Income Tax Benefit in Connection with Business Combination
Nano Crystal Technology [Member]
NanoCrystal technology
Information pertaining to NanoCrystal technology, an intangible asset acquired from third parties.
Information pertaining to OCR technology, an intangible asset acquired from third parties.
OCR Technology [Member]
OCR technology
License Agreement [Member]
Represents information pertaining to the license agreement included under the collaboration agreement.
License agreement
Manufacturing and supply agreement
Manufacturing and Supply Agreement [Member]
Represents information pertaining to the manufacturing and supply agreement included under the collaboration agreement.
Development and License Agreement [Member]
Represents information pertaining to the development and license agreement included under the collaboration agreement.
Development and license agreement
Represents Janssen, a collaborative partner of the entity.
Janssen [Member]
Janssen
Acorda [Member]
Acorda
Represents Acorda, a collaborative partner of the entity.
Bristol Myers [Member]
Bristol-Myers
Represents Bristol-Myers, a collaborative partner of the entity.
RISPERDAL CONSTA [Member]
RISPERDAL CONSTA
Represents information pertaining to RISPERDAL CONSTA, a product of the entity.
INVEGASUSTENNA or XEPLION [Member]
INVEGA SUSTENNA/XEPLION
Represents information pertaining to INVEGA SUSTENNA/XEPLION, a product of the entity.
AMPYRA or FAMPYRA [Member]
AMPYRA/ FAMPYRA
Represents information pertaining to AMPYRA/FAMPYRA, a product of the entity.
BYDUREON [Member]
BYDUREON
Represents information pertaining to BYDUREON, a product of the entity.
Represents royalty as a percentage of net sales under the collaborative agreements.
Collaborative Arrangement, Royalty Rate
Royalty rate (as a percent)
Collaborative Arrangement, Effective Notice Period Required to be Served for Termination of Agreement
Notice period required to be given before termination of agreement
Represents the notice period required to be served before the termination of the agreement.
Entity Well-known Seasoned Issuer
Period after the date of the first commercial sale of the product for license expiration
Represents the period after the date of the first commercial sale of the product in a particular country that the agreement will expire.
Collaborative Arrangement, Period after Date of First Commercial Sale of Product for Expiration of Agreement
Entity Voluntary Filers
Collaborative Arrangement, Period for Resolving Default or Breach after Receipt of Notice for Termination of Agreement
Period for resolving default or breach after the receipt of notice for termination of agreement
Represents the period for resolving default or breach after the receipt of notice for termination of agreement.
Entity Current Reporting Status
Collaborative Arrangement, Royalty Rate upon Termination of Related Agreement
Royalty rate upon termination of manufacturing and supply agreement (as a percent)
Represents royalty rate upon termination of related agreement.
Entity Filer Category
Percentage of total annual requirement of product that can be obtained from second source manufacturer under the collaborative agreement.
Collaborative Arrangement, Percentage of Total Annual Requirement of Product that Can be Obtained from Second Source Manufacturer
Percentage of total annual requirement of product that can be obtained from second source manufacturer
Entity Public Float
Collaborative Arrangement, Royalty Rate for Specified Number of Units
Royalty as a percentage of net sales from the first 40 million units
Represents royalty as a percentage of net sales of specified number of units under the collaborative arrangement.
Entity Registrant Name
Royalty as a percentage of net sales beyond the first 40 million units
Represents royalty as a percentage of net sales beyond specified number of units under the collaborative agreement.
Collaborative Arrangement, Royalty Rate Beyond Specified Number of Units
Entity Central Index Key
Represents the threshold for the number of units sold which is used to determine the royalty rate under the collaborative agreement.
Collaborative Arrangement, Number of Units Sold Threshold for Determination of Royalty Rate
Threshold for number of units sold used to determine royalty rate
The accumulated impairment losses as of the balance sheet related to intangible assets, excluding goodwill, having a projected indefinite period of benefit.
Indefinite-Lived Intangible Assets, Excluding Goodwill, Accumulated Impairment Loss
Accumulated Amortization
Intangible Assets, Net Excluding Goodwill Accumulated Amortization and Impairment Loss
Accumulated Amortization
The accumulated amortization and impairment losses related to intangible assets, excluding goodwill as of the balance sheet date.
Geographic Information
Disclosure of the entity's accounting policy for geographic information.
Geographic Information [Policy Text Block]
Entity Common Stock, Shares Outstanding
Schedule of Net Income (Loss) before Provision for Taxes by Geographical Area [Table Text Block]
Schedule of income (loss) before provision for income taxes by geographical area
Tabular disclosure of net income or loss before provision for income taxes by geographical area of the entity.
Amount of operating loss and tax credit carryforwards subject to annual limitation.
Represents the annual limitation of operating loss and tax credit carryforwards, before tax effects, that may be utilized to reduce future taxable income under enacted tax laws.
Operating Loss and Tax Credit Carryforwards Annual Limitation
Period after loss carryforwards utilized that tax returns remain open to examination
Period after Loss, Carryforwards Utilized that Tax Returns Remain Open to Examination
Represents the period after loss carryforwards have been utilized that tax returns remain open to examination.
Number of Products
Number of products
Represents the number of products.
Internal Revenue Service IRS Member and State and Local Jurisdiction [Member]
Federal, State, and Local
Represents the designated tax departments of the United States of America and state and local government entitled to levy and collect income taxes from the entity.
Ireland
IRELAND
Alkermes Europe Ltd [Member]
Alkermes Europe Ltd
Represents information pertaining to Alkermes Europe, Ltd.
Deferred Tax Liability, Related to Acquired Intellectual Property
Represents the deferred tax liability related to acquired intellectual property.
Net deferred tax liability related to acquired intellectual property
Earnings Per Share Numerator [Abstract]
Numerator:
Description of the period of time, from the grant date, after which the equity-based award expires.
Share-based Compensation Arrangement by Share-based Payment Award Expiration Term
Expiration period
Percentage of repricing premium on credit agreement being repaid if the prepayment is made in connection with a refinancing transaction
Percentage of Repricing Premium on Credit Agreement if Prepayment is Made in Connection with Refinancing Transaction
Represents the percentage of repricing premium on credit agreement being repaid if the prepayment is made in connection with a refinancing transaction.
Percentage of Repricing Premium of Outstanding Credit Agreement if Prepayment is Made in Connection with Amendment to Agreement Resulting in Refinancing Transaction
Percentage of repricing premium on outstanding credit agreement balance, if prepayment is made in connection with an amendment to the agreement resulting in a refinancing transaction
Represents the percentage of repricing premium on the outstanding credit agreement balance if the prepayment is made in connection with an amendment to the agreement resulting in a refinancing transaction.
Debt Instrument, Percentage of Present Value of Future Cash Flows Remaining under Existing Senior Credit Facilities
Percentage of present value of future cash flows remaining under Existing Senior Credit Facilities
Represents percentage of present value of the future cash flows remaining under the Existing Senior Credit Facilities.
Term Loan B 1 [Member]
Term Loan B-1
Represents the information pertaining to term loan B-1 under the new term loan facility.
Term Loan B-1, due September 25, 2019
Term Loan B 2 [Member]
Term Loan B-2
Represents the information pertaining to term loan B-2 under the new term loan facility.
Term Loan B-2, due September 25, 2016
Debt Instrument, Original Issue Discount
Original issue discount
Represents the charge against earnings during the period for the amount of debt discount recognized at the issuance of the instrument in a debt modification.
Debt Instrument, Pre-Payment Penalty
Prepayment penalty
Represents pre-payment penalty related to debt refinancing.
Debt Restructuring [Line Items]
Results of refinancing and repricing
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Document Fiscal Year Focus
Modified Debt [Abstract]
Modified debt:
Document Fiscal Period Focus
Schedule of debt refinancing interest expense recognized in condensed consolidated statement of operations and comprehensive income (loss)
Tabular disclosure of debt refinancing related information.
Schedule of Debt Refinancing Interest (Expense) [Table Text Block]
Write off of Unamortized Discount
Unamortized original issue discount
Write-off of unamortized amount of debt discount that was originally recognized at the issuance in an extinguishment of debt.
Product return reserve as percentage of product sales
Represents the sales return reserve as percentage of sales revenue goods net at the end of the period.
Sales Returns Reserve for Sales Returns as Percentage of Sales Revenue Goods Net
Accumulated Derivative Income (Loss) [Roll Forward]
Accumulated derivative loss for the interest rate swap
Number of Other Existing Investors
Number of other existing investors
Represents the number of other investors, who agreed to provide a promissory note in the specified amount.
Defined Contribution Plan Maximum Percentage of Participant Compensation Eligible for Employer Matching Contribution
Percentage of employee pay matched by the employer
Represents the maximum percentage of participants' eligible compensation for employer matching contribution.
Interest rate, variable interest rate floor
The floor for the variable rate base of the debt instrument.
Debt Instrument, Variable Rate Basis Floor
Interest rate, variable interest rate floor (as a percent)
Debt Instrument Term before Amendment
Term of loan before amendment
Represents the term of the debt instrument before amendment.
Accounting guidance related to the milestone method of revenue recognition adopted
Income Tax Benefit Recorded Relating to Utilization of Certain Net Operating Loss Carryforwards
Benefit recorded to additional paid-in capital
Represents the income tax benefit recorded related to utilization of certain net operating loss carryforwards resulting from the exercise of employee stock options.
Collaborative Arrangement Milestone Payments Entitled to be Received Upon Initiation of Phase Three Clinical Trial
Milestone payment entitled to be received upon the initiation of phase 3 clinical trial
Represents the amount of milestone payment entitled to be received upon the initiation of phase 3 clinical trial, under the collaborative arrangement.
Collaborative Arrangement Milestone Payments Entitled to be Received Upon Acceptance of New Drug Application by Food and Drug Administration
Milestone payment entitled to be received upon the acceptance of NDA by the FDA
Represents the amount of milestone payment entitled to be received upon the acceptance of NDA by the FDA, under the collaborative arrangement.
Legal Entity [Axis]
Collaborative Arrangement Milestone Payments Entitled to be Received Upon Approval of New Drug Application by Food and Drug Administration
Milestone payment entitled to be received upon the approval of NDA by the FDA
Represents the amount of milestone payment entitled to be received upon the approval of NDA by the FDA, under the collaborative arrangement.
Document Type
ASC 718
Accounting Standards Update 2010-13 [Member]
Collaborative Arrangement Milestone Payments Entitled to be Received Upon First Commercial Sale
Milestone payment entitled to be received upon the first commercial sale
Represents the amount of milestone payment entitled to be received upon the first commercial sale, under the collaborative arrangement.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nonrecourse Secured Notes Principal
RISPERDAL CONSTA secured notes percentage.
RISPERDAL CONSTA secured notes principal
Payment or purchase of non-recourse RISPERDAL CONSTA secured 7% notes attributable to original issue discount
Payment of non-recourse 7% notes principal attributable to original issue discount.
Payment of Non Recourse Product Secured Seven Percent Notes Principal Attributable to Original Issue Discount
The amount of remaining performance obligations for the achievement of milestones.
Revenue Recognition, Milestone Method Remaining Performance Obligations
Remaining Performance obligations
Represents the number of investments transferred into level 2 from level 1 of the fair value hierarchy.
Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis, Number of Investments Transfer from Level 1 to Level 2
Number of investments transferred from level 1 to level 2
Collaborative Arrangement Additional Development Milestone Payment to be Earned
Development milestone payment to be earned
Represents the amount of additional development milestone payment to be earned by the entity under the collaborative agreement.
Accounts Payable and Accrued Liabilities, Current
Accounts payable and accrued expenses
Total accounts payable and accrued expenses
Outplacement Services Costs
Outplacement services
Represents the amount of assistance that an employer provides to those employees affected by a layoff.
Accelerated Depreciation Expense [Abstract]
Expected accelerated depreciation
Accelerated Depreciation Expense for Next Twelve Months
2014
Represents the expected amount of accelerated depreciation for the next twelve months following the latest fiscal year.
Accelerated Depreciation Expense in Year Two
2015
Represents the expected amount of accelerated depreciation for the second fiscal year following the latest fiscal year.
Income tax benefit due to utilization of NOL carryforwards
Represents the amount of income tax benefit recognized due to utilization of operating loss carryforwards.
Income Tax Expense Benefit Due to Utilization of Operating Loss Carryforwards
Debt Restructuring [Table]
Schedule detailing information related to debt restructurings.
Debt Restructuring [Axis]
Information related to debt restructurings.
Debt Restructuring [Domain]
Represents type of debt restructuring.
Represents information pertaining to debt repricing by the reporting entity.
Repricing of Debt [Member]
February 2013 Repricing
Represents the maximum amount of monthly financial assistance to qualified patients, assisting them with prescription drug co-payments that their insurance requires relative to their diagnosis.
Maximum monthly co-pay assistance
Maximum Monthly Co Pay Relief to Eligible Patients
Net Impact of Timing Difference Error [Member]
Represents the errors related to uncertain tax positions driven by timing differences that were not identified and disclosed in the prior years.
Net impact of timing difference errors related to uncertain tax positions
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Employee Severance and Outplacement Services Costs [Member]
Severance and outplacement services
Represents the termination and outplacement services of employees associated with exit from or disposal of business activities or restructurings pursuant to a plan.
Represents information pertaining to the other long-term liabilities.
Other Long Term Liabilities [Member]
Other long-term liabilities
Accounts payable and accrued expenses
Gross Unrealized Gains
Available for Sale Securities Gross Unrealized Gain Accumulated in Investments
Amount of accumulated unrealized gain before deducting unrealized loss on investments in available-for-sale securities impacting investments.
Gross Unrealized Losses, Greater than One Year
Available for Sale Securities Continuous Unrealized Loss Position 12 Months or Longer Aggregate Losses Accumulated in Investments
Amount of accumulated unrealized loss on securities classified as available-for-sale securities that have been in a loss position for twelve months or longer impacting investments.
Available for Sale Securities Continuous Unrealized Loss Position Less than 12 Months Aggregate Losses Accumulated in Investments
Amount of accumulated unrealized loss on securities classified as available-for-sale securities that have been in a loss position for less than twelve months impacting investments.
Gross Unrealized Losses, Less than One Year
Amount of accumulated unrealized loss on investments in held-to-maturity securities that have been in a loss position for twelve months or longer.
Held to Maturity Securities Continuous Unrealized Loss Position 12 Months or Longer Accumulated Loss
Gross Unrealized Losses, Greater than One Year
Held to Maturity Securities Continuous Unrealized Loss Position Less than 12 Months Accumulated Loss
This item represents the excess of amortized cost basis over fair value of securities that have been in a loss position for less than 12 months for those securities which are categorized as held-to-maturity.
Gross Unrealized Losses, Less than One Year
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards, net of deferred tax liability attributable to taxable temporary differences, assumed at the acquisition date.
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Deferred Income Taxes Asset Liability Net
Deferred tax liabilities
Represents information pertaining to the paying off of an existing obligation from the proceeds of a new borrowing obtained by the entity.
Debt Refinancing [Member]
September 2012 Refinancing
Rest of world
Represents designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile, excluding the specified country.
Foreign Country Excluding Specified Country [Member]
Foreign
Schedule of Earnings Per Share [Table]
The table contains disclosure pertaining to the entity's dilutive securities.
Earnings Per Share [Line Items]
Computation of basic and diluted net income (loss) per share
Held to Maturity Securities Accumulated Unrecognized Holding Gain
Gross Unrealized Gains
Amount of accumulated unrecognized gain on investments in held-to-maturity securities.
Fair Value Measurement Conversion of Investment from Cost Method Investments to Available for Sale Securities
Conversion of investment from cost method to available-for-sale
Represents the amount of conversion of financial instrument from cost-method investments to available-for-sale securities.
Property Plant and Equipment Estimated Useful Lives [Table Text Block]
Tabular disclosure of the estimated useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Schedule of estimated useful life of property, plant and equipment
TRANSITION PERIOD COMPARATIVE DATA
Represents the entire disclosure pertaining to transition period comparative data during the reporting period.
Transition Period Comparative Data Disclosure [Text block]
TRANSITION PERIOD COMPARATIVE DATA
Schedule of Transition Period Comparative Data Disclosure [Table Text block]
Schedule of transition period comparative data
Represents the tabular disclosure pertaining to transition period comparative data during the reporting period.
Investment in Civitas Therapeutics, Inc.
The cash outflow associated with the second acquisition of investments held by the entity for investment purposes not otherwise defined in the taxonomy.
Payments to Acquire Investments Two
Collaborative Arrangement Milestone Payments Received upon First Commercial Sale
Milestone payment to be received upon the first commercial sale
Represents the amount of milestone payments received upon the first commercial sale of exenatide products, including BYDUREON, under the collaborative arrangement.
Income Tax Expense Benefit Related to Release of Valuation Allowance
Recognized benefit related to release of valuation allowance
Represents the amount of current income tax expense (benefit) and deferred income tax expense (benefit) relating to the release of a valuation allowance during the reporting period.
Astra Zeneca[Member]
AstraZeneca
Represents information pertaining to AstraZeneca, a collaborative partner of the entity.
Deferred Tax Liabilities Unrealized Gains on Securities
Unrealized gains on investment
Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on securities.
Decreases due to lapse of statute of limitations and settlement of prior period uncertain tax positions
Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations and settlement of prior period uncertain tax positions.
Unrecognized Tax Benefits Reductions Resulting from Lapse of Applicable Statute of Limitations and Settlement of Prior Period Uncertain Tax Positions
Income Tax Expense Benefit Related to Reversal of Valuation Allowance
Recognized benefit related to reversal of valuation allowance
Represents the amount of current income tax expense (benefit) and deferred income tax expense (benefit) relating to the reversal of a valuation allowance during the reporting period.
Accounts Payable and Accrued Liabilities [Member]
Accounts payable and accrued expenses
Deferred Tax Assets Tax Deferred Expense Compensation and Benefits Exercise of Stock Options and Vesting of Restricted Stock Units
Additional tax benefits from stock option exercises and the vesting of restricted stock units that have not been recognized
The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from exercise of stock options and the vesting of restricted stock units, which can only be deducted for tax purposes when actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken.
Deferred Tax Assets Tax Deferred Expense Compensation and Benefits Exercise of Stock Options and Vesting of Restricted Stock Units including Additional Tax Benefits
Total tax benefit from the exercise of stock options and the vesting of restricted stock units including unrecognized benefits
The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from exercise of stock options and the vesting of restricted stock units, which can only be deducted for tax purposes when actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken. This element includes the additional tax benefits from the exercise of stock options related to the adoption of ASC 718 that have not been recognized in the financial statements.
Deferred Tax Assets Tax Credit Carryforwards State
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state tax credit carryforwards.
State tax credits
Business Acquisition Number of Principal Drug Technology Platforms
Number of principal drug technology platforms
Represents the number of principal drug technology platforms acquired by the entity.
Schedule of Assumptions used to Determine Fair Value of Warrants [Table Text Block]
Schedule of assumptions used to determine the fair value of the warrants
Tabular disclosure of the assumptions used to determine the fair value of the warrants.
Amount of income tax expense (benefit) that has been provided on undistributed earnings of the Company's foreign subsidiaries.
Provision for Income Tax on Undistributed Earnings of Foreign Subsidiaries
Provision for income tax provided on undistributed earnings of foreign subsidiaries
Net sales of below $250.0 million
Net Sales Below 250 Million [Member]
Represents the maximum net sales under the collaborative arrangement to determine the know how royalty percentage.
Net Sales Between 250 and 500 Million [Member]
Net sales between $250.0 million and 500.0 million
Represents the range of net sales under the collaborative arrangement to determine the know-how royalty percentage.
Net Sales Greater than 500 Million [Member]
Net sales greater than $500.0 million
Represents the minimum net sales under the collaborative arrangement to determine the know-how royalty percentage.
Collaborative Arrangement Patent Royalty Rate
Patent royalty rate (as a percent)
Represents the patent royalty as a percentage of net sales under the collaborative agreements.
Know-how royalty rate (as a percent)
Collaborative Arrangement Know how Royalty Rate
Represents the know-how patent royalty as a percentage of net sales under the collaborative agreements.
Collaborative Arrangement Net Sales Tied to Know how Royalty
Aggregate worldwide net sales
Represents the aggregate worldwide net sales tied to know-how royalty under the collaborative agreements.
Share Price of Equity Investment
Current stock price (in dollars per share)
Price of a single share of a number of saleable warrants of an equity investment.
Stock Issued Issuance Costs
Offering expenses
Represents the equity offering costs related to the issuance of common during the reporting period.
Accounts payable
Accounts Payable, Current
Accounts receivable
Accounts Receivable [Member]
U.S
United States
UNITED STATES
Less: accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Accumulated other comprehensive income
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss) [Member]
Cash flow hedge
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life
Estimated useful life of intangible assets acquired
Additional paid-in capital
Additional Paid in Capital, Common Stock
Additional Paid-In Capital
Additional Paid-in Capital [Member]
Adjustments for New Accounting Pronouncements [Axis]
Adjustments for Error Correction [Domain]
Adjustments to reconcile net (loss) income to cash flows from operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Share-based compensation expense
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition
Excess tax benefit from share-based compensation
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
Total share-based compensation expense
Allocated Share-based Compensation Expense
Amortization of acquired intangible assets
Amortization expense
Amortization of Intangible Assets
Reclassification from amortization of acquired intangibles
Amortization of original issue discount and offering costs
Amortization of offering costs and discount
Amortization of Financing Costs and Discounts
Antidilutive Securities [Axis]
Denominator:
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities, Name [Domain]
Anti-dilutive potential common equivalent shares excluded from calculation of net (loss) income per share
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Accretion expense
Asset Retirement Obligation, Accretion Expense
Asset Retirement Obligations
Asset Retirement Obligation [Abstract]
Asset retirement obligation
Asset Retirement Obligations, Noncurrent
Asset Retirement Obligations
Asset Retirement Obligations, Policy [Policy Text Block]
Impairment of long-lived assets
Reclassification to impairment of long-lived assets
Impairment of assets
Asset Impairment Charges
Balance at the beginning of the period
Balance at the end of the period
Asset Retirement Obligation
Changes in the carrying amount of the company's asset retirement obligation
Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]
TOTAL ASSETS
Assets
CURRENT ASSETS:
Assets, Current [Abstract]
ASSETS
Assets [Abstract]
Total current assets
Current assets:
Assets, Current
Assets, Total
Assets, Fair Value Disclosure
Long-term assets:
Assets, Noncurrent [Abstract]
Net book value of assets
Assets Held-for-sale, at Carrying Value
Available-for-sale, Amortized Cost
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract]
Within 1 year
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value
Within 1 year
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis
Available for sale securities
Estimated Fair Value
Available-for-sale Securities
Total
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis
Investments - short-term
Available-for-sale Securities, Debt Securities, Current
Available-for-sale, Estimated Fair Value
Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]
Total
Available-for-sale Securities, Debt Maturities, without Single Maturity Date, Fair Value
Amortized Cost
Available-for-sale Securities, Amortized Cost Basis
After 1 year through 5 years
Available-for-sale Securities, Debt Maturities, Year Two Through Five, Fair Value
Available-for-sale securities:
Available-for-sale Securities [Abstract]
After 1 year through 5 years
Available-for-sale Securities, Debt Maturities, Year Two Through Five, Amortized Cost Basis
Balance Sheet Location [Axis]
Balance Sheet Location [Domain]
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Buildings and improvements
Building and Building Improvements [Member]
Prepaid expenses and other current assets
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets
Accounts payable and accrued expenses
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities
Receivables
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables
Business Acquisition [Axis]
Other long-term liabilities
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other
Cash
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents
Schedule of unaudited pro forma information
Business Acquisition, Pro Forma Information [Table Text Block]
Equity consideration in accordance with the merger agreement
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
Value of ordinary shares issued as consideration in the acquisition
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned
Acquisitions
Business Acquisition [Line Items]
Other assets
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets
Revenues
Business Acquisition, Pro Forma Revenue
Business Acquisition, Acquiree [Domain]
Net loss
Business Acquisition, Pro Forma Net Income (Loss)
ACQUISITIONS
Total purchase price
Business Combination, Consideration Transferred
Ordinary shares issued as consideration in the acquisition
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares
Inventory
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory
ACQUISITIONS
Business Combination Disclosure [Text Block]
Business Acquisitions
Business Combinations Policy [Policy Text Block]
Purchase price of the EDT business
Business Combination, Consideration Transferred [Abstract]
Property plant and equipment
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment
Acquired identifiable intangible assets
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles
Expenses related to acquisition
Business Combination, Acquisition Related Costs
Unaudited pro forma information
Business Combination, Pro Forma Information [Abstract] (Deprecated 2013-01-31)
Purchase price allocation of assets acquired and liabilities assumed
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Net loss from acquired business
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual
Revenues from acquired business
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual
Total
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net
Cash equivalents
Cash Equivalents [Member]
Cash-on-hand
Cash and Cash Equivalents [Axis]
Cash and cash equivalents
CASH AND CASH EQUIVALENTS - Beginning of period
CASH AND CASH EQUIVALENTS - End of period
Cash and Cash Equivalents, at Carrying Value
Cash and Cash Equivalents
Cash and Cash Equivalents, Policy [Policy Text Block]
Non-cash investing and financing activities:
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Designated as cash flow hedge
Cash Flow Hedging [Member]
Certificates of deposit
Certificates of Deposit [Member]
Class of Stock [Domain]
Collaborative Arrangements and Non-collaborative Arrangement Transactions
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Collaboration Agreements
Collaborative Arrangement [Member]
COLLABORATIVE ARRANGEMENTS
Collaborative Arrangement Disclosure [Text Block]
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES (Note 16)
Commitments and Contingencies.
COMMITMENTS AND CONTINGENCIES
Commitments and Contingencies Disclosure [Text Block]
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Ordinary shares, par value (in dollars per share)
Ordinary Shares
Common Stock [Member]
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 145,137,639 and 138,482,571 shares issued; 144,444,951 and 137,792,626 shares outstanding at March 31, 2014 and December 31, 2013, respectively
Common Stock, Value, Issued
Common stock, shares issued
Common Stock, Shares, Issued
Common stock, shares authorized
Common Stock, Shares Authorized
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Components of the company's net deferred tax liabilities
Components of Deferred Tax Assets and Liabilities [Abstract]
COMPREHENSIVE (LOSS) INCOME:
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Comprehensive Income (Loss)
Comprehensive Income, Policy [Policy Text Block]
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
COMPREHENSIVE (LOSS) INCOME
Concentration Risk Type [Domain]
Concentrations
Concentration Risk [Line Items]
Concentration Risk Benchmark [Domain]
Concentrations
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentration Risk Type [Axis]
Concentration Risk [Table]
Concentration Risk Benchmark [Axis]
Concentration risk percentage
Concentration Risk, Percentage
Principles of Consolidation
Consolidation, Policy [Policy Text Block]
Construction in progress
Construction in Progress [Member]
Research and development revenue
Contracts Revenue
Corporate debt securities
Corporate securities
Corporate Debt Securities [Member]
Cost of goods manufactured and sold
Cost of Goods Sold
Investment in Acceleron Pharma, Inc., a collaborative partner
Cost Method Investments
Cost of goods manufactured and sold
Cost of Sales [Member]
EXPENSES:
Costs and Expenses [Abstract]
Total expenses
Costs and Expenses
Operating expenses
Receivables
Credit Concentration Risk [Member]
Current income tax provision (benefit):
Current Income Tax Expense (Benefit), Continuing Operations [Abstract]
Current income tax provision (benefit)
Current Income Tax Expense (Benefit)
Revenue
Customer Concentration Risk [Member]
Designated as hedging instrument
Designated as Hedging Instrument [Member]
Variable rate base
Variable interest rate base
Debt Instrument, Description of Variable Rate Basis
Long-term debt
Debt Instrument [Line Items]
Schedule of Long-term Debt Instruments [Table]
Debt Conversion, Converted Instrument, Shares Issued
Number of shares of Series B preferred stock issued on conversion of promissory note
Fair value of remaining financial instruments not recognized at fair value
Aggregate principal amount
Debt Instrument, Face Amount
Estimated Fair Value
Debt Instrument, Fair Value Disclosure
Interest rate, basis spread (as a percent)
Interest rate added to base rate (as a percent)
Debt Instrument, Basis Spread on Variable Rate
LONG-TERM DEBT
Debt Security [Axis]
Conversion of promissory note into shares of Civitas Series B Preferred Stock
Debt Conversion, Converted Instrument, Amount
Amount of promissory note converted into Series B preferred stock
Term loans maturity period
Term of loan
Debt Instrument, Term
Offering costs
Original issue discount
Unamortized original issue discount
Debt Instrument, Unamortized Discount
Stated interest rate (as a percent)
RISPERDAL CONSTA secured notes (as a percent)
Stated interest rate on promissory note (as a percent)
Debt Instrument, Interest Rate, Stated Percentage
Required quarterly principal payments
Scheduled principal payment
Debt Instrument, Periodic Payment, Principal
Debt financing costs
Debt Related Commitment Fees and Debt Issuance Costs
Property, plant and equipment
Deferred Tax Assets, Property, Plant and Equipment
Current deferred tax liabilities
Deferred Tax Liabilities, Gross, Current
Non-current deferred tax liabilities
Deferred Tax Liabilities, Gross, Noncurrent
Intangible assets
Deferred Tax Assets, Goodwill and Intangible Assets
Unamortized deferred financing costs at period end
Deferred Finance Costs, Net
Deferred income tax (benefit) provision:
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Deferred income taxes
Deferred tax benefit
Deferred income tax (benefit) provision
Deferred Income Tax Expense (Benefit)
Net deferred tax liabilities
Deferred tax liability related to acquired intellectual property
Deferred Tax Assets, Net
Current deferred tax assets
Deferred Tax Assets, Gross, Current
Deferred revenue from milestone payment received prior to April 1, 2011
Deferred Revenue
Deferred revenue - current
Deferred revenue, short-term
Deferred Revenue, Current
Deferred revenue
Deferred Tax Assets, Deferred Income
DEFERRED REVENUE - LONG-TERM
Deferred revenue, long-term
Deferred Revenue, Noncurrent
Share-based compensation
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
Bonus accrual
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses
Other
Deferred Tax Assets, Other
Total deferred tax assets
Deferred Tax Assets, Net of Valuation Allowance
Federal research and development credits
Deferred Tax Assets, Tax Credit Carryforwards, Research
Deferred tax assets :
Deferred Tax Assets, Net [Abstract]
NOL carryforwards
Deferred Tax Assets, Operating Loss Carryforwards
Alternative minimum tax
Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax
Tax credit carryforwards
Deferred Tax Assets, Tax Credit Carryforwards
Less: valuation allowance
Deferred Tax Assets, Valuation Allowance
Other
Deferred Tax Liabilities, Other
DEFERRED TAX LIABILITIES, NET - LONG-TERM
Deferred Tax Liabilities, Net, Noncurrent
Property, plant and equipment
Deferred Tax Liabilities, Property, Plant and Equipment
Intangible assets
Deferred tax liability related to acquired intellectual property
Deferred Tax Liabilities, Intangible Assets
Total deferred tax liabilities
Deferred Tax Liabilities, Net
Deferred tax liabilities :
Deferred Tax Liabilities, Gross [Abstract]
Maximum percentage of employer contribution matched of employee's
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent
Percentage of employer contribution matched of the first employee pay
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay
Employer contribution
Defined Contribution Plan, Cost Recognized
Depreciation expense
Depreciation
Depreciation and amortization
Depreciation, Depletion and Amortization
Cost of interest rate cap
Derivative, Cost of Hedge
Interest rate swap contract
Derivative Liability
Derivative instruments
Risk-management instruments
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net
Derivative Instrument [Axis]
Derivative [Table]
Gain on derivative instrument due to change in fair value of the contract
Derivative Instruments Not Designated as Hedging Instruments, Loss
DERIVATIVE INSTRUMENTS
Derivative Instruments and Hedging Activities Disclosure [Text Block]
DERIVATIVE INSTRUMENTS
Interest rate cap contracts
Derivative Asset
Fair value of derivative instrument
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value
Fair value of derivative instrument
Unrealized losses included in accumulated other comprehensive income, at the beginning of the period
Unrealized losses included in accumulated other comprehensive income, at the end of the period
Derivative Liability, Fair Value, Gross Liability
Summary of the effect of derivatives designated as hedging instruments on the condensed consolidated statements of operations and comprehensive income (loss)
Derivative, Gain (Loss) on Derivative, Net [Abstract]
Unrealized losses included in accumulated other comprehensive income, at the end of the period
Derivative, Loss on Derivative
Derivative Contract [Domain]
Risk-Management Instruments
Derivatives, Policy [Policy Text Block]
Directors
Director [Member]
SHARE-BASED COMPENSATION
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
SHARE-BASED COMPENSATION
Irish
Accrued compensation
Due to Employees, Current
EU
European Union [Member]
(LOSS) EARNINGS PER SHARE
Earnings Per Share [Text Block]
Earnings (Loss) Per Share
Earnings Per Share, Policy [Policy Text Block]
Basic (in dollars per share)
Earnings Per Share, Basic
Earnings per ordinary share - basic
Diluted (in dollars per share)
Earnings Per Share, Diluted
Earnings per ordinary share - diluted
(LOSS) EARNINGS PER ORDINARY SHARE:
(LOSS) EARNINGS PER SHARE
Estimated cost savings
Effect on Future Earnings, Offset Amount
Effective tax rate (as a percent)
Effective Income Tax Rate Reconciliation, Percent
R&D credit (as a percent)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
Reconciliation of the company's federal statutory tax rate to its effective rate
Effective Income Tax Rate Reconciliation, Percent [Abstract]
U.S. state income taxes, net of U.S. federal benefit (as a percent)
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
Permanent items (as a percent)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Change in valuation allowance (as a percent)
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Statutory tax rate (as a percent)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
State tax law change
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent
Share-based compensation (as a percent)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Percent
Rate differential (as a percent)
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent
Non-refundable withholding tax (as a percent)
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent
Share-based Compensation Expense
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock options
Stock options
Employee Stock Option [Member]
Share based compensation cost capitalized
Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount
Unrecognized compensation cost
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized
Weighted average period for unrecognized compensation cost expected to be recognized
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition
SHAREHOLDERS' EQUITY
Increase in carrying value of equity method investment
Equity Method Investment, Deferred Gain on Sale
Carrying value of equity investment
Equity Method Investments
Ownership percentage
Equity Method Investment, Ownership Percentage
Investment, Name [Domain]
Equity Component [Domain]
Equity securities
Equity Securities [Member]
Adjustments for Error Corrections [Axis]
Reclassifications
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total
Estimate of Fair Value Measurement [Member]
Excess tax benefit from share-based compensation
Excess Tax Benefit from Share-based Compensation, Operating Activities
Excess tax benefit from share-based compensation
Reclassification to excess tax benefit from share-based compensation
Excess Tax Benefit from Share-based Compensation, Financing Activities
Extinguished debt:
Extinguishment of Debt Disclosures [Abstract]
Intangible assets acquired, finite-lived
Finite-lived Intangible Assets Acquired
Athlone, Ireland manufacturing facility
Facility Closing [Member]
Measurement Frequency [Axis]
Volatility (as a percent)
Fair Value Assumptions, Expected Volatility Rate
Fair Value Measurements, Recurring and Nonrecurring [Table]
Fair Value, Hierarchy [Axis]
Investments transferred into Level 3
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3
Discount rate (as a percent)
Fair Value Inputs, Discount Rate
Investments transferred out of Level 3
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3
Recurring basis
Fair Value, Measurements, Recurring [Member]
Fair Value, Measurement Frequency [Domain]
Risk-free rate (as a percent)
Fair Value Assumptions, Risk Free Interest Rate
Expected term
Fair Value Assumptions, Expected Term
Transfer of securities from level 1 to level 2
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount
Warrant strike price (in dollars per share)
Fair Value Assumptions, Exercise Price
Assumptions used to determine the fair value of the warrants
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total unrealized losses included in other comprehensive (loss) income
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)
FAIR VALUE MEASUREMENTS
Fair Value Hierarchy [Domain]
Estimated fair value of term loans
Fair Value Measurements, Nonrecurring [Table Text Block]
Fair Value of Financial Instruments
Fair Value of Financial Instruments, Policy [Policy Text Block]
FAIR VALUE MEASUREMENTS
Fair Value Disclosures [Text Block]
Roll forward of the fair value of the Company's investments whose fair value was determined using Level 3 inputs
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Estimated fair value of the Term Loans
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, by Balance Sheet Grouping [Table]
Schedule of rollforward of the fair value of the Company's investments whose fair value was determined using Level 3 inputs
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Level 3
Fair Value, Inputs, Level 3 [Member]
Balance at the beginning of the period
Balance at the end of the period
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
Level 1
Fair Value, Inputs, Level 1 [Member]
Level 2
Fair Value, Inputs, Level 2 [Member]
Weighted Amortizable Life
Finite-Lived Intangible Asset, Useful Life
Gross Carrying Amount
Finite-Lived Intangible Assets, Gross
2018
Finite-Lived Intangible Assets, Amortization Expense, Year Five
2016
Finite-Lived Intangible Assets, Amortization Expense, Year Three
Expected amortization of intangible assets
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization
Net Carrying Amount
Expected amortization of intangible assets
Finite-Lived Intangible Assets, Net
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-lived intangible assets:
Finite-Lived Intangible Assets, Net [Abstract]
2017
Finite-Lived Intangible Assets, Amortization Expense, Year Four
2015
Finite-Lived Intangible Assets, Amortization Expense, Year Two
2014
Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year
Foreign Currency
Foreign Currency Transactions and Translations Policy [Policy Text Block]
International government agency debt securities
Foreign Government Debt Securities [Member]
Ireland
Foreign Tax Authority [Member]
Gain on foreign currency translation
Foreign Currency Transaction Gain (Loss), before Tax
Foreign Currency
Foreign Currency Translation [Abstract]
Loss on purchase of non-recourse RISPERDAL CONSTA secured 7% Notes
Gain (Loss) on Non-Recourse Debt
Loss on debt refinancing transaction
Total
Gains (Losses) on Extinguishment of Debt
Goodwill and Intangible Assets
Goodwill and Intangible Assets, Policy [Policy Text Block]
Impairment of goodwill
Goodwill, Impairment Loss
GOODWILL
Goodwill
Goodwill
GOODWILL AND INTANGIBLE ASSETS
Goodwill and Intangible Assets Disclosure [Text Block]
Gross Carrying Amount
Goodwill, Gross
GOODWILL AND INTANGIBLE ASSETS
Hedging Designation [Axis]
Hedging Designation [Domain]
Held-to-maturity, Estimated Fair Value
Held-to-maturity Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]
Within 1 year
Held-to-maturity Securities, Debt Maturities, Next Twelve Months, Fair Value
After 1 year through 5 years
Held-to-maturity Securities, Debt Maturities, Year Two Through Five, Fair Value
Held-to-maturity, Amortized Cost
Held-to-maturity Securities, Debt Maturities, Net Carrying Amount [Abstract]
Amortized Cost
Held-to-maturity Securities, Amortized Cost before Other than Temporary Impairment
Total
Held-to-maturity Securities
After 1 year through 5 years
Held-to-maturity Securities, Debt Maturities, after One Through Five Years, Net Carrying Amount
Held-to-maturity securities:
Held-to-maturity Securities, Parenthetical Disclosure [Abstract]
Gain (loss) on sale of held-to-maturity securities
Held-to-maturity Securities, Sold Security, Realized Gain (Loss)
Within 1 year
Held-to-maturity Securities, Debt Maturities, within One Year, Net Carrying Amount
Sale of held-to-maturity securities
Held-to-maturity Securities, Sold Security, at Carrying Value
Estimated Fair Value
Held-to-maturity Securities, Fair Value
Intangible assets acquired, indefinite-lived
Indefinite-lived Intangible Assets Acquired
Impairment charge
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
Impairment of Long-Lived Assets
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]
Reduction in carrying value of investment of the entity, which represents the Company's share of investee's net losses
Income (Loss) from Equity Method Investments
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME
Statement of Operations Data:
(LOSS) INCOME BEFORE INCOME TAXES
Income (loss) before the provision for income taxes
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest
Income Statement Location [Axis]
INCOME TAXES
Income Tax Authority [Domain]
Income Tax Authority [Axis]
INCOME TAXES
Income Tax Disclosure [Text Block]
Income Statement Location [Domain]
Components of company's (benefit) provision for income taxes
Income Tax Expense (Benefit), Continuing Operations [Abstract]
Income tax (benefit) provision
INCOME TAX PROVISION
Income tax provision (benefit)
Income Tax Expense (Benefit)
Cash paid for taxes
Income Taxes Paid
Income Taxes
Income Tax, Policy [Policy Text Block]
Accounts payable and accrued expenses
Reclassification from accounts payable and accrued expenses
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Deferred revenue
Increase (Decrease) in Deferred Revenue
Other long-term liabilities
Increase (Decrease) in Other Operating Liabilities
Changes in assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Receivables
Increase (Decrease) in Receivables
Increase (Decrease) in Shareholders' Equity
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dilutive ordinary share equivalents (in shares)
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
Indefinite-lived Intangible Assets [Axis]
Gross carrying amount
Indefinite-Lived Intangible Assets (Excluding Goodwill)
Indefinite-lived Intangible Assets, Major Class Name [Domain]
Indefinite-lived intangible assets:
Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]
Intangible assets
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Gross carrying amount
Intangible Assets, Gross (Excluding Goodwill)
INTANGIBLE ASSETS - NET
Net Carrying Amount
Intangible Assets, Net (Excluding Goodwill)
Intangible assets
Accrued interest
Interest Payable, Current
Interest expense
Interest Expense
Cash paid for interest
Interest Paid
Interest rate swap contract
Interest rate swap
Interest Rate Swap [Member]
Interest rate caps
Interest rate cap contracts
Interest Rate Cap [Member]
Federal
U.S. Federal
Internal Revenue Service (IRS) [Member]
Inventory
Total inventory
Inventory, Net
Finished goods
Inventory, Finished Goods, Net of Reserves
Raw materials
Inventory, Raw Materials, Net of Reserves
INVENTORY
Inventory Disclosure [Text Block]
Inventory
Inventory, Policy [Policy Text Block]
INVENTORY
Work in process
Inventory, Work in Process, Net of Reserves
Interest income
Investment Income, Interest
Investments
Investment, Policy [Policy Text Block]
Investments [Domain]
Investments
Investment Holdings [Line Items]
Investment Type [Axis]
Investment Holdings [Table]
The cost and fair value of available-for-sale and held-to-maturity securities by contractual maturity
Investments Classified by Contractual Maturity Date [Table Text Block]
Estimated Fair Value
Investments, Fair Value Disclosure
INVESTMENTS
LIBOR
London Interbank Offered Rate (LIBOR) [Member]
Long-term Debt, Type [Axis]
Long-term Debt, Type [Domain]
Land
Land [Member]
Leasehold improvements
Leasehold Improvements [Member]
Total current liabilities
Liabilities, Current
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities and Equity
CURRENT LIABILITIES:
Liabilities, Current [Abstract]
Total liabilities
Liabilities
LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities and Equity [Abstract]
Liabilities, Total
Financial and Nonfinancial Liabilities, Fair Value Disclosure
Collaboration agreements
Licensing Agreements [Member]
Credit Agreement
New Term Loan Facility
Line of Credit [Member]
2013
2015
Total
Carrying Value
Long-term Debt.
2016
2014
LONG-TERM DEBT
Long-term Debt [Text Block]
Thereafter
2017
2015
Long-term Debt, Maturities, Repayments of Principal in Year Two
2017
Long-term Debt, Maturities, Repayments of Principal in Year Four
2018
Long-term Debt, Maturities, Repayments of Principal in Year Five
Thereafter
Long-term Debt, Maturities, Repayments of Principal after Year Five
2016
Long-term Debt, Maturities, Repayments of Principal in Year Three
Long-term debt - current
Less: current portion
Long-term Debt, Current Maturities
LONG-TERM DEBT
Long-term debt
Long-term Debt, Excluding Current Maturities
2014
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months
Major Types of Debt Securities [Domain]
Major Types of Debt and Equity Securities [Axis]
Major Types of Debt and Equity Securities [Domain]
Customer [Axis]
Total investments
Marketable Securities [Abstract]
Gross Unrealized Gains
Marketable Securities, Unrealized Gain (Loss)
INVESTMENTS - LONG-TERM
Marketable Securities, Noncurrent
INVESTMENTS
Marketable Securities [Table Text Block]
Scheduled maturities of Credit Agreement
Maturities of Long-term Debt [Abstract]
Maximum
Maximum [Member]
Minimum
Minimum [Member]
Money market funds
Money Market Funds [Member]
Long-term assets:
Long-Lived Assets
Customer [Domain]
THE COMPANY
Nature of Operations [Text Block]
CASH FLOWS FROM FINANCING ACTIVITIES:
Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
NET DECREASE IN CASH AND CASH EQUIVALENTS
Net Cash Provided by (Used in) Continuing Operations
NET (LOSS) INCOME
Net income (loss)
Net Income (Loss) Available to Common Stockholders, Basic
Net (loss) income
Cash flows (used in) provided by operating activities
Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Cash flows provided by operations
Cash flows provided by financing activities
Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Cash flows provided by (used in) financing activities
Cash flows used in investing activities
Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Cash flows (used in) provided by investing activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]
Net income (loss)
Net Income (Loss) Attributable to Parent
Increase in product sales, net
New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Net Revenue
New accounting pronouncements
New Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Investment in Civitas Therapeutics, Inc.
Noncash or Part Noncash Acquisition, Investments Acquired
Purchased capital expenditures included in accounts payable and accrued expenses
Noncash or Part Noncash Acquisition, Value of Liabilities Assumed
Total other (expense), net
Nonoperating Income (Expense)
Other expense (net)
OTHER (EXPENSE), NET:
Nonoperating Income (Expense) [Abstract]
Non-voting Common Stock
Nonvoting Common Stock [Member]
Promissory note
Financing Receivable, Gross
Number of business segments
Number of Reportable Segments
Not designated as hedging instrument
Not Designated as Hedging Instrument [Member]
Thereafter
Operating Leases, Future Minimum Payments, Due Thereafter
Future minimum rental commitments under non-cancelable operating leases
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2017
Operating Leases, Future Minimum Payments, Due in Four Years
2018
Operating Leases, Future Minimum Payments, Due in Five Years
Rent expense related to operating leases
Operating Leases, Rent Expense, Net [Abstract]
Sublease income
Operating Leases, Rent Expense, Sublease Rentals
2016
Operating Leases, Future Minimum Payments, Due in Three Years
Rent expense
Operating Leases, Rent Expense, Net
2014
Operating Leases, Future Minimum Payments Due, Next Twelve Months
OPERATING (LOSS) INCOME
Operating Income (Loss)
Less: estimated sublease income
Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals
2015
Operating Leases, Future Minimum Payments, Due in Two Years
Lease Commitments
Operating Leased Assets [Line Items]
Total future minimum lease payments before estimated sublease income
Operating Leases, Future Minimum Payments Due
Operating loss carryforwards
Operating Loss Carryforwards
THE COMPANY
Unrealized (losses) gains on derivative contracts
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax
Unrealized gains on marketable securities, tax
Other Comprehensive Income (Loss), Available-for-sale Securities, Tax
Unrealized gains on marketable securities, net of tax of $8,217 and $372 for nine months ended December 2013 and and twelve months ended March 2012 respectively
Unrealized (losses) gains on marketable securities
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax
Less: Reclassification adjustment for gains included in net income (loss)
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax
Reclassification of unrealized gains to realized gains
Less: Reclassification adjustment for losses included in net income (loss)
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax
Reclassification of unrealized losses to realized losses
OTHER ASSETS
Other Assets, Noncurrent
Other
Unrealized gains (losses) on marketable securities
Unrealized gains (losses) on marketable securities, net of tax:
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax [Abstract]
Holding (losses) gains, net of tax of $1,453 and none, respectively
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax
Unrealized losses on derivative contracts, net of tax of none, none and $(194), respectively
Unrealized losses incurred during the period
Unrealized loss on cash flow hedge, net of tax of $(194) for twelve months ended March 2012
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax
Holding (losses) gains, tax
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax
Unrealized (losses) gains on derivative contracts:
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Unrealized loss on cash flow hedge, tax
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax
Unrealized losses on derivative contracts, tax
Less: Reclassification adjustment for losses included in net (loss) income
Unrealized losses
Other Income
Consigned-out inventory
Other Inventory, Net of Reserves
Other non-cash charges
Other Noncash Expense
Other (expense) income, net
Other Nonoperating Income (Expense)
OTHER LONG-TERM LIABILITIES
Other Liabilities, Noncurrent
Adjustments
Other Restructuring Costs
Accrued other
Other Accrued Liabilities, Current
Unrealized gains (losses) on marketable securities
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent
Products and Services [Domain]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
Reclassification to employee taxes paid related to net share settlement of equity awards
Employee taxes paid related to net share settlement of equity awards
Payments Related to Tax Withholding for Share-based Compensation
Acquisition of Elan Drug Technologies, net of cash acquired
Payments to Acquire Businesses, Net of Cash Acquired
Cash paid for restructuring costs
Payments for Restructuring
Cash paid for acquisition
Upfront payment in accordance with the merger agreement
Payments to Acquire Businesses, Gross
Additions of property, plant and equipment
Payments to Acquire Property, Plant, and Equipment
Promissory note issued to Civitas Therapeutics, Inc.
Payments to Acquire Notes Receivable
Investment in Acceleron Pharmaceuticals, Inc.
Payments to Acquire Other Investments
Additional investments
Employee Benefit Plans
Pension and Other Postretirement Plans, Nonpension Benefits, Policy [Policy Text Block]
Plan Name [Domain]
Plan Name [Axis]
Preferred shares, par value (in dollars per share)
Preferred Stock, Par or Stated Value Per Share
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at March 31, 2014 and December 31, 2013, respectively
Preferred Stock, Value, Issued
Preferred shares, issued
Preferred Stock, Shares Issued
Preferred shares, authorized
Preferred Stock, Shares Authorized
Preferred shares, outstanding
Preferred Stock, Shares Outstanding
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Reclassifications
Reclassification, Policy [Policy Text Block]
Proceeds from (Repayments of) Notes Payable
Payment or purchase of non-recourse RISPERDAL CONSTA secured 7% notes
Proceeds from the issuance of long-term debt
Proceeds from Issuance of Long-term Debt
Gross proceeds from issuance
Proceeds from Issuance of Common Stock
Proceeds from the issuance of ordinary shares, net
Cash received from option exercises
Proceeds from Stock Options Exercised
Sales and maturities of investments
Proceeds from the sales and maturities of marketable securities
Proceeds from Sale and Maturity of Marketable Securities
Proceeds from the sale of equipment
Proceeds from sale of property, plant and equipment
Proceeds from Sale of Property, Plant, and Equipment
Proceeds from the issuance of ordinary shares under share-based compensation arrangements
Reclassification from proceeds from the issuance of ordinary shares under share-based compensation arrangements
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options
Products and Services [Axis]
Estimated useful life
Property, Plant and Equipment, Useful Life
Subtotal
Property, Plant and Equipment, Gross
Carrying value at the time of disposition
Property, Plant and Equipment, Disposals
Property, Plant and Equipment
Property, Plant and Equipment, Policy [Policy Text Block]
PROPERTY, PLANT AND EQUIPMENT, NET
Total property, plant and equipment, net
Property, Plant and Equipment, Net
Net book value of assets
PROPERTY, PLANT AND EQUIPMENT
Schedule of property, plant and equipment
Property, Plant and Equipment [Table Text Block]
Property, Plant and Equipment, Type [Domain]
Property, Plant and Equipment, Type [Axis]
PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment Disclosure [Text Block]
Property, plant and equipment
Property, Plant and Equipment [Line Items]
Reclassification of property plant and equipment
Property, Plant and Equipment, Transfers and Changes
Open purchase order commitments
Purchase Commitment, Remaining Minimum Amount Committed
Out-of-period adjustment recorded to correct an over-accrued liability from the prior year
Quantifying Misstatement in Current Year Financial Statements, Amount
Range [Axis]
Range [Domain]
Receivables
Receivables, Net, Current
Reclassification
Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification out of Accumulated Other Comprehensive Income [Domain]
Reclassification out of Accumulated Other Comprehensive Income [Axis]
Reconciliation of the beginning and ending amount of unrecognized tax benefits
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Principal payments of long-term debt
Repayments of Long-term Debt
Repayment of term loan
Repayments of Debt
IPR&D
In-process research and development
Research and Development Arrangement [Member]
Research and development
Research and Development Expense
Research and development
Research and Development Expense [Member]
Research and Development Expenses
Research and Development Expense, Policy [Policy Text Block]
Adjustments
Restatement Adjustment [Member]
Restricted stock units
Restricted Stock [Member]
Restructuring accrual
Restructuring Reserve [Abstract]
RESTRUCTURING
Restructuring Charges [Abstract]
Restructuring
Total
Payments
Restructuring Charges
Foreign currency adjustment
Restructuring Reserve, Translation Adjustment
Restructuring activity
Restructuring and Related Cost [Line Items]
Number of employees eliminated
Restructuring and Related Cost, Number of Positions Eliminated
Restructuring Type [Axis]
Balance at end of the period
Balance at beginning of the period
Restructuring accrual
Restructuring Reserve
Accrued restructuring
Expected number of employees to be eliminated
Restructuring and Related Cost, Expected Number of Positions Eliminated
RESTRUCTURING
Restructuring activity
Restructuring Reserve [Roll Forward]
RESTRUCTURING
Restructuring and Related Activities Disclosure [Text Block]
RESTRUCTURING
Accumulated Deficit
Retained Earnings [Member]
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Revenue Recognition
Revenue Recognition [Abstract]
Revenue Recognition
Revenue Recognition, Policy [Policy Text Block]
Product return reserve
Revenue Recognition, Sales Returns, Reserve for Sales Returns
Revenue recognized
Revenue by region:
Revenues
Geographic Information
Revenues from External Customers and Long-Lived Assets [Line Items]
Expected option term
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term
Weighted average contractual remaining life
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Weighted average remaining contractual term of stock options exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
Product sales, net
Sales Revenue, Goods, Net
Total revenues
Revenue, Net
Revenues
REVENUES:
Revenue, Net [Abstract]
Scenario, Unspecified [Domain]
Purchase price allocation of assets acquired and liabilities assumed
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Summary of the Company's assets and liabilities measured at fair value on a recurring basis
Schedule of Change in Asset Retirement Obligation [Table Text Block]
Schedule of changes in the carrying amount of the company's asset retirement obligation
Schedule of anti-dilutive potential ordinary equivalent shares excluded from calculation of net (loss) income per share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Summary of stock option activity
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Schedule of Revenues from External Customers and Long-Lived Assets [Table]
Summary of time-vested RSU activity
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]
Schedule of fair value of each stock option grant estimated on the grant date using weighted-average assumptions
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of components of company's (benefit) provision for income taxes
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
Schedule of long-term debt
Schedule of Debt [Table Text Block]
Scheduled maturities with respect to the Term Loan Facility
Schedule of Maturities of Long-term Debt [Table Text Block]
Schedule of goodwill and intangible assets
Schedule of Intangible Assets and Goodwill [Table Text Block]
Schedule of inventories
Schedule of Inventory, Current [Table Text Block]
Schedule of reconciliation of the company's federal statutory tax rate to its effective tax rate
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule of components of the company's net deferred tax liabilities
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Schedule of reconciliation of the beginning and ending amount of unrecognized tax benefits
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]
Schedule of future minimum rental commitments under non-cancelable operating leases
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Schedule of revenues by geographic location, as determined by the location of the customer, and the location of its long-term assets
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Schedule of weighted average number of ordinary shares outstanding, as adjusted for the effect of potential outstanding shares, including stock options and restricted stock units
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Summary of changes in accumulated derivative loss for the interest rate swap
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Schedule of accounts payable and accrued expenses
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Schedule of Business Acquisitions, by Acquisition [Table]
Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]
Schedule of Operating Leased Assets [Table]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Investment, Name [Axis]
Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]
Schedule of Equity Method Investments [Table]
Equity method investment
Schedule of Equity Method Investments [Line Items]
Schedule of share-based compensation expense
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
Schedule of Restructuring and Related Costs [Table]
Property, Plant and Equipment [Table]
Schedule of restructuring charges recorded
Restructuring and Related Costs [Table Text Block]
Summary of restructuring activity during the period
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of fair value and presentation in the condensed consolidated balance sheets for derivatives designated and not designated as hedging instruments
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
Schedule of revenue and receivables from customers exceeding 10% of total in each category
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
Term Loans
2013 Term Loans
Secured Debt [Member]
Segment Information
Segment Reporting [Abstract]
Segment Information
Segment Reporting, Policy [Policy Text Block]
Geographical [Domain]
Selling, General and Administrative Expenses [Member]
Selling, general and administrative
Selling, general and administrative
Selling, General and Administrative Expense
Severance
Severance Costs
Additional disclosures
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
Derived service period
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period
Additional disclosures
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Granted (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Forfeited (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Unvested at the beginning of the period (in shares)
Unvested at the end of the period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Expected stock volatility, maximum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Expected stock volatility, minimum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested (in shares)
Share-based compensation expense
Share-based Compensation.
Risk-free interest rate, maximum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Vesting period
Minimum vesting period
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period
Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based compensation
Share-Based Compensation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested at the beginning of the period (in dollars per share)
Unvested at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Forfeited (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited (in shares)
Share Price
Share price (in dollar per share)
Current stock price (in dollars per share)
Purchase price (in dollar per share)
Expired (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Risk-free interest rate, minimum (as a percent)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Exercised (in dollars per share)
Granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Exercisable at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Estimated dividend yield (as a percent)
Expected annual dividend yield (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
Fair value of RSU's vested
Expired (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Forfeited (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Vested (in dollars per share)
Exercisable at the end of the period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Additional disclosures
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Shares of common stock authorized for issuance
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant
Aggregate intrinsic value of stock options exercised
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Shares of common stock authorized for issuance
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Weighted-average assumptions
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Weighted average grant-date fair value of stock options granted (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]
Stock options expected to vest
Outstanding at the beginning of the period (in dollars per share)
Outstanding at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Aggregate intrinsic value of stock options exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Share-Based Compensation
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Outstanding at the beginning of the period (in shares)
Outstanding at the end of the period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Stock options expected to vest (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Equity Award [Domain]
Weighted average exercise price (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Aggregate intrinsic value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
BALANCE (in shares)
BALANCE (in shares)
Shares, Issued
Short-term investments
Short-term Investments [Member]
Net reduction unrecognized tax benefits expected resolution of certain matters
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Significant Accounting Policies [Text Block]
U.S. state
State and Local Jurisdiction [Member]
State
Scenario [Axis]
Statement [Table]
Statement
Statement [Line Items]
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
Geographical [Axis]
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Statement of Cash Flows Data:
Equity Components [Axis]
CONDENSED CONSOLIDATED BALANCE SHEETS
Class of Stock [Axis]
Stock Issued During Period, Shares, Period Increase (Decrease)
Issuance of common stock to Elan Corporation, plc in connection with the purchase of Elan Drug Technologies (in shares)
Stock Issued During Period, Shares, Acquisitions
Value of shares authorized under repurchase program
Stock Repurchase Program, Authorized Amount
Issuance of common stock to Elan Corporation, plc in connection with the purchase of Elan Drug Technologies
Stock Issued During Period, Value, Acquisitions
Conversion of non-voting common stock to common stock
Stock Issued During Period, Value, Conversion of Convertible Securities
Issuance of common stock used in the acquisition of Elan Drug Technologies
Stock Issued
Issuance of common stock under employee stock plans (in shares)
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures
Exercised (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Ordinary shares sold
Stock Issued During Period, Shares, New Issues
Number of ordinary shares sold
Conversion of non-voting common stock to common stock (in shares)
Stock Issued During Period, Shares, Conversion of Convertible Securities
Issuance of common stock under employee stock plans
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures
Value of shares available for repurchase pursuant to repurchase program
Stock Repurchase Program, Remaining Authorized Repurchase Amount
SHAREHOLDERS' EQUITY:
Stockholders' Equity Attributable to Parent [Abstract]
Stockholders' Equity, Period Increase (Decrease)
Total shareholders' equity
BALANCE
BALANCE
Stockholders' Equity Attributable to Parent
SHAREHOLDERS' EQUITY
Stockholders' Equity Note Disclosure [Text Block]
SUBSEQUENT EVENTS
Subsequent Events [Text Block]
SUBSEQUENT EVENTS
Subsequent Event [Table]
Subsequent events
Subsequent Event [Line Items]
Subsequent event
Subsequent Event [Member]
Subsequent Event Type [Domain]
Subsequent Event Type [Axis]
SUPPLEMENTAL CASH FLOW DISCLOSURE:
Supplemental Cash Flow Information [Abstract]
Title of Individual [Axis]
Relationship to Entity [Domain]
Trademark
Trademarks [Member]
Cancellation of treasury stock (in shares)
Treasury Stock, Shares, Retired
Treasury share
Treasury Stock, Shares
Cancellation of treasury stock
Treasury Stock, Retired, Cost Method, Amount
Treasury Stock
Treasury Stock [Member]
Treasury shares, at cost (692,688 and 689,945 shares at March 31, 2014 and December 31, 2013, respectively)
Treasury Stock, Value
Type of Arrangement and Non-arrangement Transactions [Axis]
Type of Adoption [Domain]
Type of Restructuring [Domain]
Cumulative unremitted earnings of overseas subsidiaries
Undistributed Earnings of Foreign Subsidiaries
Additions based on tax positions related to the current period
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Decreases due to settlements with tax authorities
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
Unrecognized tax benefit that would affect effective tax rate
Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Decreases due to lapse of statute of limitations
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
Balance at the beginning of the period
Balance at the end of the period
Unrecognized Tax Benefits
Discrete benefit from the settlement of uncertain tax benefits
Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities
Additions based on tax positions related to prior periods
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
U.S. government obligations
US Government Debt Securities [Member]
U.S. government and agency debt securities
US Government Agencies Debt Securities [Member]
Decrease in the valuation allowance due to the utilization of NOLs
Valuation Allowance, Deferred Tax Asset, Change in Amount
Variable Rate [Domain]
Variable Rate [Axis]
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES OUTSTANDING:
Denominator:
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Effect of dilutive securities:
Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]
Basic (in shares)
Weighted average number of ordinary shares outstanding
Weighted Average Number of Shares Outstanding, Basic
Weighted average ordinary shares outstanding - basic
Diluted (in shares)
Shares used in calculating diluted (loss) earnings per share
Weighted Average Number of Shares Outstanding, Diluted
Weighted average ordinary shares outstanding - diluted
Unamortized deferred financing costs
Write off of Deferred Debt Issuance Cost